China NT Pharma Group Company Limited (HKG:1011)
Hong Kong · Delayed Price · Currency is HKD 0.7500
0.00 (0.00%)
At close: Feb 13, 2026
HKG:1011 Revenue
China NT Pharma Group Company had revenue of 12.00M CNY in the half year ending June 30, 2025, with 62.84% growth. This brings the company's revenue in the last twelve months to 18.66M, down -3.48% year-over-year. In the year 2024, China NT Pharma Group Company had annual revenue of 37.96M with 415.34% growth.
Revenue (ttm)
18.66M CNY
Revenue Growth
-3.48%
P/S Ratio
24.73
Revenue / Employee
888.48K CNY
Employees
21
Market Cap
505.68M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 37.96M | 30.59M | 415.34% |
| Dec 31, 2023 | 7.37M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 226.70M | 4.97M | 2.24% |
| Dec 31, 2020 | 221.73M | 68.26M | 44.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition